ArthroCare Corp (ARTC.OQ)

ARTC.OQ on NASDAQ Stock Exchange Global Select Market

48.61USD
17 Apr 2014
Price Change (% chg)

$0.11 (+0.23%)
Prev Close
$48.50
Open
$48.51
Day's High
$48.62
Day's Low
$48.50
Volume
156,048
Avg. Vol
129,968
52-wk High
$49.94
52-wk Low
$31.61

ARTC.OQ

Chart for ARTC.OQ

About

ArthroCare Corporation (ArthroCare), is a medical device company. ArthroCare develops and manufactures surgical devices, instruments, and implants. Its devices enable surgical procedures and enable new minimally invasive procedures. Many of ArthroCare's devices use its Coblation technology. This technology dissolves target... (more)

Overall

Beta: 0.77
Market Cap (Mil.): $1,670.82
Shares Outstanding (Mil.): 34.37
Dividend: --
Yield (%): --

Financials

  ARTC.OQ Industry Sector
P/E (TTM): 76.23 96.12 33.35
EPS (TTM): 0.64 -- --
ROI: 5.35 5.33 18.92
ROE: 4.83 5.28 19.68
Search Stocks

BRIEF-OFT to consider Arthrocare Corps acquisition by Smith & Nephew

* Considering whether anticipated acquisition by Smith & Nephew plc of Arthrocare Corporation may result in substantial lessening of competition within UK Source text for Eikon: Further company coverage:

26 Mar 2014

Smith&Nephew in $1.7 billion deal to tackle sports injuries

LONDON - Britain's Smith & Nephew is to buy ArthroCare Corp for an agreed $1.7 billion in cash to strengthen its treatments for sporting injuries, an area growing faster than its main replacement hips and knees business.

03 Feb 2014

UPDATE 3-Smith&Nephew in $1.7 bln deal to tackle sports injuries

* To pay $48.25 a share cash, 20 pct above 90-day average

03 Feb 2014

Smith & Nephew buys sports medicine firm ArthroCare for $1.7 bln

LONDON, Feb 3 - Artificial knee and hip maker Smith & Nephew said on Monday it had agreed to buy medical devices company ArthroCare Corp for $1.7 billion to strengthen its sports medicine business.

03 Feb 2014

ArthroCare signs deal to end fraud prosecution, to pay $30 million fine

- ArthroCare Corp said it signed an agreement with the U.S. Department of Justice to resolve a six-year long investigation regarding allegations of securities and related fraud committed under a previous management team.

07 Jan 2014

ArthroCare signs deal to end fraud prosecution, to pay $30 mln fine

Jan 7 - ArthroCare Corp said it signed an agreement with the U.S. Department of Justice to resolve a six-year long investigation regarding allegations of securities and related fraud committed under a previous management team.

07 Jan 2014

BRIEF-ArthroCare shares up 10.9 pct after the bell following announcement of deferred prosecution agreement

NEW YORK, Jan 7 - ArthroCare Corp : * Arthrocare corp shares up 10.9 pct after the bell following

07 Jan 2014

Competitors

  Price Change
Medtronic, Inc. (MDT.N) $58.55 +0.06
Smith & Nephew plc (SN.L) 866.00p +5.50
Stryker Corporation (SYK.N) $78.78 -0.27
Johnson & Johnson (JNJ.N) $98.96 +0.21
Olympus Corp (7733.T) ¥2,990 +26.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks